tiprankstipranks
Advertisement
Advertisement

IMTX Stock Latest News

Immatics initiated with a Buy at TD Cowen
The FlyImmatics initiated with a Buy at TD Cowen
4d ago
IMTX
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
PremiumCompany Announcements
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
11d ago
6K
IMTX
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
PremiumCompany Announcements
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
15d ago
6K
IMTX
Immatics abstract accepted for late-breaking poster presentation at AACR meeting
PremiumThe Fly
Immatics abstract accepted for late-breaking poster presentation at AACR meeting
15d ago
IMTX
Immatics assumed with a Buy at Jefferies
PremiumThe Fly
Immatics assumed with a Buy at Jefferies
2M ago
IMTX
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
PremiumCompany AnnouncementsImmatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
2M ago
6K
IMTX
Immatics sees cash runway into 2028
Premium
The Fly
Immatics sees cash runway into 2028
2M ago
IMTX
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
Premium
The Fly
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
2M ago
IMTX
Immatics price target raised to $25 from $23 at Mizuho
PremiumThe Fly
Immatics price target raised to $25 from $23 at Mizuho
2M ago
IMTX
Immatics’ treatment of Stage II and higher CM granted FDA orphan designation
PremiumThe Fly
Immatics’ treatment of Stage II and higher CM granted FDA orphan designation
3M ago
IMTX
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026
PremiumCompany Announcements
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026
4M ago
6K
IMTX
Immatics price target raised to $17 from $14 at BofA
PremiumThe Fly
Immatics price target raised to $17 from $14 at BofA
4M ago
IMTX
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
PremiumCompany AnnouncementsImmatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
5M ago
6K
IMTX
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
Premium
The Fly
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
5M ago
IMTX
Immatics Completes $116.5 Million Share Offering to Boost R&D
Premium
Company Announcements
Immatics Completes $116.5 Million Share Offering to Boost R&D
5M ago
6K
IMTX
Immatics announces offering of 12.5M ordinary shares
PremiumThe Fly
Immatics announces offering of 12.5M ordinary shares
5M ago
IMTX
Immatics N.V. Reports Q3 2025 Financial Results and Progress
PremiumCompany Announcements
Immatics N.V. Reports Q3 2025 Financial Results and Progress
5M ago
IMTX
Immatics price target raised to $23 from $19 at Mizuho
PremiumThe Fly
Immatics price target raised to $23 from $19 at Mizuho
5M ago
IMTX
Immatics price target raised to $19 from $16 at Guggenheim
PremiumThe Fly
Immatics price target raised to $19 from $16 at Guggenheim
5M ago
IMTX
Morning Movers: E.W. Scripps surges after report of Sinclair takeover interest
PremiumThe FlyMorning Movers: E.W. Scripps surges after report of Sinclair takeover interest
6M ago
SEE
SSP
Immatics Reports Q3 2025 Financial Results and Business Update
Premium
Company Announcements
Immatics Reports Q3 2025 Financial Results and Business Update
6M ago
6K
IMTX
Immatics reports Q3 EPS (EUR 0.42) vs (EUR 0.08) vs last year
Premium
The Fly
Immatics reports Q3 EPS (EUR 0.42) vs (EUR 0.08) vs last year
6M ago
IMTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >